JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 33 No. 8 1550-1551
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBouthillier, G.
Right arrow Articles by Pomier, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LeBouthillier, G.
Right arrow Articles by Pomier, G.

Scintigraphic Aspect of Rotor's Disease with Technetium-99m-Mebrofenin

Gilles LeBouthillier, Jacques Morais, Michel Picard, Daniel Picard, Raymonde Chartrand and Gilles Pomier

Divisions of Nuclear Medicine and Hepatology, Hôpital Saint-Luc, Université de Montréal, Montreal, Canada

Correspondence: For reprints contact: Doctor Jacques Morals, Nuclear Medicine Service, Hôpital Saint-Luc, 1058 St-Denis, Montréal, Quebec, Canada, H2X 3J4.

ABSTRACT

A 28-yr-old male with Rotor's disease was studied with 99mTc-mebrofenin. The scintigraphic pattern was that of a slow liver uptake with unimpaired excretion and persistent visualization of the cardiac blood pool, kidneys and urinary tract up to 6 hr. The gallbladder was visualized at 55 min postinjection.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1992 by the Society of Nuclear Medicine.